Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1456

1.

The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.

Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, Healey JH, Ueda T, Yoshikawa H, Meloni-Ehrig A, Sorensen PH, Mertens F, Mandahl N, van den Berghe H, Sciot R, Dal Cin P, Bridge J.

Oncogene. 2001 Jan 4;20(1):48-57.

2.

Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M.

Am J Pathol. 2001 Jul;159(1):179-92.

3.

Alveolar soft part sarcoma--reciprocal translocation between chromosome 17q25 and Xp11. Report of a case with metastases at presentation and review of the literature.

Uppal S, Aviv H, Patterson F, Cohen S, Benevenia J, Aisner S, Hameed M.

Acta Orthop Belg. 2003 Apr;69(2):182-7.

PMID:
12769020
4.

Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.

Pang LJ, Chang B, Zou H, Qi Y, Jiang JF, Li HA, Hu WH, Chen YZ, Liu CX, Zhang WJ, Li F.

Diagn Mol Pathol. 2008 Dec;17(4):245-52. doi: 10.1097/PDM.0b013e31815d68d7.

PMID:
18382356
5.

Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.

Aulmann S, Longerich T, Schirmacher P, Mechtersheimer G, Penzel R.

Histopathology. 2007 Jun;50(7):881-6.

PMID:
17543078
6.
7.

Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas.

Heimann P, El Housni H, Ogur G, Weterman MA, Petty EM, Vassart G.

Cancer Res. 2001 May 15;61(10):4130-5.

8.

[Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].

Pang LJ, Li F, Chang B, Hu WH, Lu TC, Li XX, Li HA, Jiang JF.

Zhonghua Bing Li Xue Za Zhi. 2004 Dec;33(6):508-12. Chinese.

PMID:
15634444
9.

Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2003 Jun;27(6):750-61.

PMID:
12766578
10.

Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.

Williams A, Bartle G, Sumathi VP, Meis JM, Mangham DC, Grimer RJ, Kindblom LG.

Virchows Arch. 2011 Mar;458(3):291-300. doi: 10.1007/s00428-010-1039-9. Epub 2011 Jan 29.

PMID:
21279521
11.

Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.

Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, Ladanyi M, Chilosi M, Argani P.

Mod Pathol. 2011 Oct;24(10):1313-9. doi: 10.1038/modpathol.2011.93. Epub 2011 May 20.

12.

Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas.

Martignoni G, Pea M, Gobbo S, Brunelli M, Bonetti F, Segala D, Pan CC, Netto G, Doglioni C, Hes O, Argani P, Chilosi M.

Mod Pathol. 2009 Aug;22(8):1016-22. doi: 10.1038/modpathol.2009.58. Epub 2009 Apr 24.

13.

Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.

Vistica DT, Krosky PM, Kenney S, Raffeld M, Shoemaker RH.

J Pediatr Hematol Oncol. 2008 Jan;30(1):46-52. doi: 10.1097/MPH.0b013e31815d1d6f.

PMID:
18176180
14.

Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.

Reis H, Hager T, Wohlschlaeger J, Bauer S, Katenkamp K, Katenkamp D, Baba HA.

Hum Pathol. 2013 Oct;44(10):2266-74. doi: 10.1016/j.humpath.2013.04.018. Epub 2013 Jul 17.

PMID:
23871289
15.

Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.

Hoshino M, Ogose A, Kawashima H, Izumi T, Hotta T, Hatano H, Morita T, Otsuka H, Umezu H, Yanoma S, Tsukuda M, Endo N.

Cancer Genet Cytogenet. 2009 Apr 15;190(2):75-80. doi: 10.1016/j.cancergencyto.2008.11.014.

PMID:
19380023
16.

PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, Hafez N, Ladanyi M.

Am J Surg Pathol. 2002 Dec;26(12):1553-66.

PMID:
12459622
17.

A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

Argani P, Lui MY, Couturier J, Bouvier R, Fournet JC, Ladanyi M.

Oncogene. 2003 Aug 14;22(34):5374-8.

PMID:
12917640
18.

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.

Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.

19.

Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.

Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT.

Mod Pathol. 2014 Jan;27(1):113-27. doi: 10.1038/modpathol.2013.83. Epub 2013 Jul 5.

20.

The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene.

Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS.

Hum Mol Genet. 1996 Sep;5(9):1333-8.

PMID:
8872474

Supplemental Content

Support Center